Aurélien Lorleac'h, MD

CH BRETAGNE SUD
LORIENT, Bretagne, France

Disclosure(s): Gilead: Hospitality; GSK: Hospitality; Nestlé Home Care: Hospitality; ViiV Healthcare: Hospitality

Presentation(s):

• 82 - Comparative Evaluation of Low Versus High Doses of Rifampin for the Treatment of Staphylococcal Bone and Joint Infections: an open-label, randomized, controlled non-inferiority trial (EVRIOS)

  Thursday, October 17, 2024
  10:30 AM – 10:45 AM US PT